Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Altman

Showing results (201-210 of 675) with videos related to

Pageof 68
Sort By:
Bioinformatics (Oxford, England)|October 9, 2009
Knowledge-based instantiation of full atomic detail into coarse-grain RNA 3D structural modelsMagdalena A Jonikas, Randall J Radmer, Russ B Altman
Clinical Pharmacology and Therapeutics|August 24, 2007
The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB)R P Owen, T E Klein, R B Altman
Clinical Pharmacology and Therapeutics|July 25, 2014
Interpreting the CYP2D6 results from the International Tamoxifen Pharmacogenetics ConsortiumM A Province, R B Altman, T E Klein
Nucleic Acids Research|July 31, 2003
Microenvironment analysis and identification of magnesium binding sites in RNAD Rey Banatao, Russ B Altman, Teri E Klein
Briefings in Bioinformatics|December 1, 2021
Challenges and opportunities in network-based solutions for biological questionsMargaret G Guo, Daniel N Sosa, Russ B Altman
Bioinformatics (Oxford, England)|March 9, 1999
Using imperfect secondary structure predictions to improve molecular structure computationsC C Chen, J P Singh, R B Altman
Pharmacogenomics|March 31, 2010
Pharmacogenomics and bioinformatics: PharmGKBCaroline F Thorn, Teri E Klein, Russ B Altman
Journal of Medical Internet Research|March 25, 2015
Ranking adverse drug reactions with crowdsourcingAssaf Gottlieb, Robert Hoehndorf, Michel Dumontier, et al.
Gene|May 6, 1997
RNA secondary structure as a reusable interface to biological information resourcesR M Felciano, R O Chen, R B Altman
Pharmacogenetics and Genomics|November 10, 2009
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzymeCaroline F Thorn, Teri E Klein, Russ B Altman
Pageof 68

Showing results (201-210 of 675) with videos related to

Sort By:
Pageof 68
Bioinformatics (Oxford, England)|October 9, 2009
Knowledge-based instantiation of full atomic detail into coarse-grain RNA 3D structural modelsMagdalena A Jonikas, Randall J Radmer, Russ B Altman
Clinical Pharmacology and Therapeutics|August 24, 2007
The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB)R P Owen, T E Klein, R B Altman
Clinical Pharmacology and Therapeutics|July 25, 2014
Interpreting the CYP2D6 results from the International Tamoxifen Pharmacogenetics ConsortiumM A Province, R B Altman, T E Klein
Nucleic Acids Research|July 31, 2003
Microenvironment analysis and identification of magnesium binding sites in RNAD Rey Banatao, Russ B Altman, Teri E Klein
Briefings in Bioinformatics|December 1, 2021
Challenges and opportunities in network-based solutions for biological questionsMargaret G Guo, Daniel N Sosa, Russ B Altman
Bioinformatics (Oxford, England)|March 9, 1999
Using imperfect secondary structure predictions to improve molecular structure computationsC C Chen, J P Singh, R B Altman
Pharmacogenomics|March 31, 2010
Pharmacogenomics and bioinformatics: PharmGKBCaroline F Thorn, Teri E Klein, Russ B Altman
Journal of Medical Internet Research|March 25, 2015
Ranking adverse drug reactions with crowdsourcingAssaf Gottlieb, Robert Hoehndorf, Michel Dumontier, et al.
Gene|May 6, 1997
RNA secondary structure as a reusable interface to biological information resourcesR M Felciano, R O Chen, R B Altman
Pharmacogenetics and Genomics|November 10, 2009
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzymeCaroline F Thorn, Teri E Klein, Russ B Altman
Pageof 68